Objective: the experiment for the patients with branch retinal vein occlusion, and under the inspection found that the western medicine treatment of patients with macular edema, on the choice of scheme for the glass b...Objective: the experiment for the patients with branch retinal vein occlusion, and under the inspection found that the western medicine treatment of patients with macular edema, on the choice of scheme for the glass body cavity injection of compaq heap joint retinal laser photocoagulation for treatment, thus improved compared to the patient, and eyesight state changes. Methods: Patients diagnosed with branch retinal vein occlusion in our hospital and found with macular edema under examination were selected as the study subjects. The diagnosis and treatment time was from January 2018 to December 2020, and 50 patients were randomly divided into groups according to the order of treatment by drawing lots. The control group was treated with fundus laser, while the observation group was treated with intravitreal injection of Compaxerib combined with retinal laser photocoagulation, and the therapeutic effects were compared. Results: From the point of view of treatment, the BCVA index score of the best corrected visual acuity in the observation group was higher than that in the control group at one and three months, and the comparison was statistically significant. Meanwhile, in terms of CMT index of retinal thickness in macular fovea, we compared the efficacy of patients treated for one month, and it was (264.94±101.35) um in the observation group and (344.56±123.48) um in the control group, the difference was statistically significant. In terms of therapeutic efficacy, the observation group was 92.0%, which was higher than the control group's 68.0%. Therefore, it was believed that the observation group was more ideal in the improvement of the condition, and the difference was statistically significant. Conclusion: Intravitreal injection of combocipropionate combined with retinal laser photocoagulation is effective in the treatment of macular edema caused by branch retinal vein occlusion. It has high clinical feasibility and is worthy of wide application.展开更多
文摘Objective: the experiment for the patients with branch retinal vein occlusion, and under the inspection found that the western medicine treatment of patients with macular edema, on the choice of scheme for the glass body cavity injection of compaq heap joint retinal laser photocoagulation for treatment, thus improved compared to the patient, and eyesight state changes. Methods: Patients diagnosed with branch retinal vein occlusion in our hospital and found with macular edema under examination were selected as the study subjects. The diagnosis and treatment time was from January 2018 to December 2020, and 50 patients were randomly divided into groups according to the order of treatment by drawing lots. The control group was treated with fundus laser, while the observation group was treated with intravitreal injection of Compaxerib combined with retinal laser photocoagulation, and the therapeutic effects were compared. Results: From the point of view of treatment, the BCVA index score of the best corrected visual acuity in the observation group was higher than that in the control group at one and three months, and the comparison was statistically significant. Meanwhile, in terms of CMT index of retinal thickness in macular fovea, we compared the efficacy of patients treated for one month, and it was (264.94±101.35) um in the observation group and (344.56±123.48) um in the control group, the difference was statistically significant. In terms of therapeutic efficacy, the observation group was 92.0%, which was higher than the control group's 68.0%. Therefore, it was believed that the observation group was more ideal in the improvement of the condition, and the difference was statistically significant. Conclusion: Intravitreal injection of combocipropionate combined with retinal laser photocoagulation is effective in the treatment of macular edema caused by branch retinal vein occlusion. It has high clinical feasibility and is worthy of wide application.
